Post by Temple OrthoBio

Temple ORTHOBiologics, a new venture spun-out from Temple Therapeutics, is proud to announce its official launch on September 9th heralding a breakthrough in #orthopedic #sportsmedicine. Co-Founder Riley J Williams III, MD of Hospital for Special Surgery in NYC, calls TX-33, the company's flagship product "a game changer!" For years, the prevention of #scartissue was considered impossible. Temple ORTHOBiologics is changing that narrative. With a world-class "Ocean's 12" team Jens Thies Vinod Dasa MD Shaun Patel, MD Pieter Emans Raphael Guzman Emily Renna, MS Neville Wright, OLY Jennifer Raoul Samuel Ogunsalu Sanj Singh Steven D. Spence and its R&D hub located in Liège, Belgium, USA, The Netherlands and strategic partnerships in the UK and Canada, the Company is positioned to drive cutting-edge #innovation to address the rising volume of knee and other #joint #injuries or #surgeries.